123 related articles for article (PubMed ID: 7741926)
21. [A new experimental trial for dissolution of gallbladder stones].
Shimoda I; Ishizuka H; Murakami M; Sato K; Hirano H; Tanno N; Ohira C; Koizumi M; Toyota T
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2481. PubMed ID: 2593314
[No Abstract] [Full Text] [Related]
22. Soybean trypsin inhibitor and cerulein accelerate recovery of cerulein-induced pancreatitis in rats.
Jurkowska G; Grondin G; Massé S; Morisset J
Gastroenterology; 1992 Feb; 102(2):550-62. PubMed ID: 1370663
[TBL] [Abstract][Full Text] [Related]
23. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
[TBL] [Abstract][Full Text] [Related]
24. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
Hirano T; Manabe T
Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
[TBL] [Abstract][Full Text] [Related]
25. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
[TBL] [Abstract][Full Text] [Related]
26. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of human pancreatic secretory trypsin inhibitor on cerulein-induced acute pancreatitis in rats.
Funakoshi A; Miyasaka K; Jimi A; Kitani K; Teraoka H; Yoshida N
Digestion; 1992; 52(3-4):145-51. PubMed ID: 1459347
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
[TBL] [Abstract][Full Text] [Related]
29. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
Ge YC; Morgan RG
Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
[TBL] [Abstract][Full Text] [Related]
30. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007.
Hirano T; Manabe T; Tobe T
Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836
[TBL] [Abstract][Full Text] [Related]
31. Induction of apoptosis with an extract of Artemisia asiatica attenuates the severity of cerulein-induced pancreatitis in rats.
Hahm KB; Kim JH; You BM; Kim YS; Cho SW; Yim H; Ahn BO; Kim WB
Pancreas; 1998 Aug; 17(2):153-7. PubMed ID: 9700946
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice.
Makovec F; Bani M; Cereda R; Chistè R; Revel L; Rovati LC; Setnikar I; Rovati LA
Peptides; 1986; 7(6):1159-64. PubMed ID: 3104890
[TBL] [Abstract][Full Text] [Related]
33. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
[TBL] [Abstract][Full Text] [Related]
34. [Antienzyme preparations in the treatment of acute pancreatitis].
Yoshida K; Toki F; Takeuchi T
Nihon Rinsho; 1990 Jan; 48(1):165-72. PubMed ID: 1689401
[No Abstract] [Full Text] [Related]
35. Effects of the synthetic trypsin inhibitor camostate on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
Meijers M; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Cancer Lett; 1991 Dec; 60(3):205-11. PubMed ID: 1756510
[TBL] [Abstract][Full Text] [Related]
36. Camostat, an oral trypsin inhibitor, reduces pancreatic fibrosis induced by repeated administration of a superoxide dismutase inhibitor in rats.
Emori Y; Mizushima T; Matsumura N; Ochi K; Tanioka H; Shirahige A; Ichimura M; Shinji T; Koide N; Tanimoto M
J Gastroenterol Hepatol; 2005 Jun; 20(6):895-9. PubMed ID: 15946137
[TBL] [Abstract][Full Text] [Related]
37. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
von Schönfeld J; Rünzi M; Goebell H; Müller MK
Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
[TBL] [Abstract][Full Text] [Related]
38. [Effect of FOY-305 on post-operative reflux esophagitis in rats (II). Analysis of mechanism in the pathogenesis of reflux esophagitis after total gastrectomy in rats].
Kamiyasu K; Inoshiri S; Omawari N; Okegawa T; Kawasaki A
Nihon Yakurigaku Zasshi; 1991 May; 97(5):251-7. PubMed ID: 1879803
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic microvascular permeability in caerulein-induced acute pancreatitis.
Sweiry JH; Mann GE
Am J Physiol; 1991 Oct; 261(4 Pt 1):G685-92. PubMed ID: 1928354
[TBL] [Abstract][Full Text] [Related]
40. [Protease inhibitors in the treatment of pancreatitis].
Takeda K
Nihon Rinsho; 1991 Sep; 49(9):2125-9. PubMed ID: 1720472
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
